These include FARP1 (found in 2 RASGRF2 fusions from cholangiocarcinoma and PDAC) and MSH3 (found in 6 RASGRF2 fusions from colorectal, ovarian, head and neck, pancreatic, and prostate cancers; Fig. 2f). This evidence concerns the gene RASGRF2 and cholangiocarcinoma.